 |
Elliot Marseille
UC Berkeley
Elliot Marseille, DrPH, MPP, is a health economist whose work sits at the intersection of psychedelic science, public health, and policy. He directs the Collaborative for the Economics of Psychedelics at UC Berkeley, where he and collaborators develop rigorous, decision-relevant analyses of psychedelic-assisted therapies—spanning cost-effectiveness, access, pricing, and implementation. The work of CEP is designed to inform payers, regulators, and health systems on coverage and scale-up.
|
 |
Sherry Rais
Enthea
Sherry Rais is the CEO and Co-Founder of Enthea, which provides the most innovative, evidence-based mental health solutions through employee benefit plans – ensuring safe, affordable access to treatments that actually work. Under her leadership, Enthea has grown from a pilot program to serving over 300,000 covered lives nationwide, delivering unmatched outcomes for depression, anxiety, and PTSD – while helping employers reduce costs, improve retention, and boost workforce well-being. She has worked in over 35 countries with the United Nations and the World Bank, and holds degrees from the London School of Economics and McGill University. A sought-after speaker at events like HLTH, BenefitsPRO, and SXSW, Sherry shares how forward-thinking employers can transform mental health benefits to improve outcomes, reduce costs, and boost workforce well-being.
|
 |
Chris Raine
The Psychedelic Consultancy (Australia)
Chris Raine is a mental healthcare entrepreneur and executive dedicated to pioneering innovative treatments for addiction and mental health. He founded Hello Sunday Morning, a non-profit organisation that established one of the world’s largest online communities supporting individuals recovering from alcohol dependence. Chris also co-founded Clean Slate Clinic, a telehealth service delivering home-based alcohol detox programs, which has successfully supported over 2,000 detoxes across Australia. As a 2024 Kenneth Myer Innovation Fellow, Chris spent 12 months contributing to the establishment of Australia’s psychedelic-assisted therapy system, developing extensive relationships and deep insights that enabled treatment access for the first 100 patients.
|
 |
Dara Menashi
Psychedelic Mental Health Access Alliance
Dara Menashi, Ph.D., is a Co-Director of the Psychedelic Mental Health Access Alliance, where she focuses on developing Medicaid fundable care models and creating the evidence Medicaid needs to cover psychedelic assisted therapies. She is a systems reform expert who previously led child welfare finance reforms at the Annie E. Casey Foundation that helped shape federal legislation, and she now advises donors and mission-driven health organizations on strategies to expand access to effective care for marginalized communities.
|
